Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Profs Enzo Cerundolo and Ahmed Ahmed, winners of the Ovarian Cancer Action International Grand Challenge Award.

Painting of the fallopian tubes © Susan Lockhart CC BY-NC

The £600,000 award will support research on new ways to enhance immune responses for the treatment of ovarian cancer.

Around 7,500 women are diagnosed with ovarian cancer in the UK each year, making it the 6th most common cancer in women. A significant proportion of ovarian cancers harbour tumour infiltrating lymphocytes, suggesting that immunotherapy strategies might improve prognosis. However, checkpoint inhibitor therapies have so far been of limited success, in contrast with other types of cancers such as melanoma. There is therefore an unmet need for the development of complimentary immunotherapeutic strategies.

The project now funded by Ovarian Cancer Action aims to establish a translation-ready therapeutic platform for treating ovarian cancer patients. The project will focus on adoptive T cell therapies, where patient T cells are expanded in vitro and then re-administered to the patient, with the aim of enhancing the immune response to the tumour. Adoptive T cell therapies have shown great promise in ovarian cancer, but specificity and efficacy are still lacking. This project will specifically look at the selection, isolation and expansion of neo-epitope-specific T cells, and will take advantage of the Cerundolo group’s expertise on immunotherapy and the Ahmed group’s work on ovarian cancer genomics and human organoids.

“We are very excited for winning this award. This work will enable us to investigate novel immunotherapeutic approaches for treating ovarian cancer patients.” said Prof Ahmed. The announcement was made at the Ovarian Cancer Action Research Awards Ceremony last week, hosted by the Royal College of Obstetricians and Gynaecologists.

A PhD studentship is currently available to contribute to this project, with an application deadline of the 10th of January. Prospective applicants can find more information about this opportunity here.

 

 

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.